ArticleCancers2025

Dynamic Integrative Immune Profiling Reveals Early Biomarkers of Response and Prognosis in Advanced Gastric Cancer Treated with Nivolumab Plus Chemotherapy.

Hyunho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.